TY - CHAP
T1 - Bridging from multiscale modeling to practical clinical applications in the study of human gliomas
AU - Chakraborty, Gargi
AU - Sodt, Rita
AU - Massey, Susan
AU - Gu, Stanley
AU - Rockne, Russell
AU - Alvord, Ellsworth C.
AU - Swanson, Kristin R.
N1 - Publisher Copyright:
© 2011 by Taylor & Francis Group, LLC.
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Gliomas are malignant lesions of the brain characterized by their propensity to proliferate and invade the normal-appearing tissue. These brain tumors show diverse anatomic and metabolic traits that manifest differently across patients, ranging in aggressiveness from low-grade gliomas (LGGs) to high-grade gliomas (HGGs). Approximately 50% of glioma patients are diagnosed with glioblastoma multiforme (GBM), a World Health Organization grade IV glioma, which is the most aggressive type of brain tumor in adults (Louis et al. 2007). Difficulty in treating gliomas arises primarily from the invasiveness of the cell populations comprising the tumor. Despite extensive treatments including surgical resection, radiotherapy, and chemotherapy, GBMs have a propensity to recur and prove to be fatal with a median survival of approximately 1 year (Burnet et al. 2007; Welsh et al. 2009).
AB - Gliomas are malignant lesions of the brain characterized by their propensity to proliferate and invade the normal-appearing tissue. These brain tumors show diverse anatomic and metabolic traits that manifest differently across patients, ranging in aggressiveness from low-grade gliomas (LGGs) to high-grade gliomas (HGGs). Approximately 50% of glioma patients are diagnosed with glioblastoma multiforme (GBM), a World Health Organization grade IV glioma, which is the most aggressive type of brain tumor in adults (Louis et al. 2007). Difficulty in treating gliomas arises primarily from the invasiveness of the cell populations comprising the tumor. Despite extensive treatments including surgical resection, radiotherapy, and chemotherapy, GBMs have a propensity to recur and prove to be fatal with a median survival of approximately 1 year (Burnet et al. 2007; Welsh et al. 2009).
UR - http://www.scopus.com/inward/record.url?scp=85055381853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055381853&partnerID=8YFLogxK
U2 - 10.1201/b10407
DO - 10.1201/b10407
M3 - Chapter
AN - SCOPUS:85055381853
SN - 9781439814406
SP - 359
EP - 375
BT - Multiscale Cancer Modeling
PB - CRC Press
ER -